emerging tech investing DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
emerging tech investing DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
emerging tech investing DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
emerging tech investing DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
emerging tech investing DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence Scientist to Accelerate our Innovation in Healthcare
emerging tech investing Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
emerging tech investing Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
emerging tech investing DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
emerging tech investing DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
emerging tech investing DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
Golconda Gold Announces the Election of Paul Olmsted and James Colter Eadie to the Board of Directors
Standard Uranium Initiates 2026 Drill Program at the Davidson River Uranium Project, Southwest Athabasca Basin
Nuvau Minerals commences PEA study to advance Matagami restart strategy, which includes a fully permitted critical metals mine
